• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Metastatic potential and prognostic significance of SOX2:A metaanalysis

    2019-08-22 01:53:34ArslaanJavaeedSanniyaKhanGhauri
    World Journal of Clinical Oncology 2019年6期

    Arslaan Javaeed, Sanniya Khan Ghauri

    Abstract

    Key words: Tumor progression; SOX2; Cancer; Cancer stem cell markers; Lymphatic metastasis

    INTRODUCTION

    The mechanisms by which the metastatic cascade is instigated and developed have merited the attention of the researchers worldwide. Tumor metastasis involves a sequential process, comprising cell invasion through the basement membrane and extracellular matrix followed by intravasation to access the vascular or lymphatic circulation, extravasation out of the circulatory system, and eventually distant localization and proliferation[1]. Failure to manage distant dissemination of cancer cells causes a significant mortality burden, with approximately 1500 cancer spreadrelated deaths reported daily[2]. A plethora of studies has been conducted on animal models to outline the metastatic phenotype. These studies usually employ intravenous injections for metastatic initiation. However, such an approach lacks the appropriate characterization of the origin of metastasis and, thus, multiple triggering factors are either still hypothesized or their contribution in metastasis is not fully delineated.

    Of these factors, the transcription factor sex determining region Y-box 2 (SOX2) has been recently integrated in cancer biology[3]. SOX2 is one of the SOX proteins that has≥ 50% similarity in the amino acid structure to a specific domain (HMG domain) of the sex-determining region located on the Y chromosome (Sry)[4]. The encoding gene was initially discovered in 1994 in human, being located on chromosome 3q26.3-q27[5]. Heterozygous mutations of theSOX2gene result in the development of anophthalmia syndrome, which includes an aberrant development of endodermal and ectodermal tissues[6]. SOX2 is an important regulator of pluripotent cellular transcription and is a crucial factor implicated in the development and maintenance of undifferentiated embryonic stem cells. Besides, it contributes to somatic cell reprogramming back towards pluripotent features and this process was shown to be co-induced by ectopic expression ofcMyc,Klf4, andOct4[3].

    Intriguingly, this discovery highlighted the role of SOX2 expression in different types of cancers.SOX2gene amplification or increased expression has been demonstrated in malignancy, yet its involvement in the most important aspects of patient survival and metastasis remains relatively unclear. Herein, we provide analytic insight into the association between metastasis and SOX2 expression in cancer patients, along with its relation to the prognostic profile.

    MATERIALS AND METHODS

    A meta-analysis was conducted on studies that investigated the relationship between development of a metastatic phenotype as well as the prognostic significance of such expression. The general outline of the study was based on the guidelines in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (commonly known as PRISMA)[7].

    Eligibility criteria

    The included studies investigated at least the association of SOX2 expression,reported as “l(fā)ow” or “high” expression levels, and either lymph node metastasis(LNM) or distant metastasis (DM). When appropriate, patients' prognosis should have been evaluated using survival analysis, where the overall survival (OS) and/or disease-free survival (DFS) were reported. Only peer-reviewed studies conducted on male or female human patients were considered. The cancer patients should have been diagnosed using pathological examinations. Studies were excluded if they provided insufficient data to be extracted or had employed animal subjects solely.Furthermore, non-English articles, case reports, reviews and cell experiments were omitted.

    Information sources

    The following scientific databases were used for the search process:MEDLINE,Embase, Cochrane Library, and Google Scholar. Additionally, the bibliographies of the screened articles were thoroughly searched for eligible studies.

    Search strategy

    Two authors performed the search process using the following key words:(“transcription factor sex determining region Y-box 2” OR “SOX2”) AND (“cancer”O(jiān)R “metastasis”) AND (“prognosis” OR “survival” OR “hazard”). The publication dates of the included studies were limited to those articles published between 2010 and 2018, to attain the most recent evidence. Screening of the titles and abstracts was performed and the relevant articles were obtained for subsequent assessment of the full-texts. Any disagreement was resolved by discussion.

    Data collection

    A specifically-designated form was used in Microsoft Excel spreadsheet software(version 2016) to extract data. The extracted data for each study were categorized into four main categories:(1) Study and patients' characteristics, including the name of the first author, publication date, methods of detection of SOX2 expression, method of survival analysis, reported outcomes, number of samples, type of primary cancer, sex of patients, frequency of SOX2 expression (low or high), and clinical stage (I and II or III and IV); (2) Primary outcomes, including the frequency of reported samples with low or high SOX2 expression in the regional lymph nodes (i.e. LNM) or distant organs(i.e. DM); (3) Clinicopathological parameters, including SOX2 expression levels according to patients' age, sex, clinical stage, and tumor size and differentiation; (4)Prognostic data, including direct extraction of the hazard ratios (HRs) and their respective 95% confidence intervals (CIs) of the OS and/or DFS. When both univariate and multivariate analyses were used for survival analysis, multivariate tests were preferentially used.

    Quality assessment

    A specialized scale for quality assessment was used [i.e.,. Newcastle-Ottawa scale(commonly known as NOS)][8], which employs a scoring system comprising nine items and yielding a total score of 0 to 9 for low-quality to high-quality articles,respectively. The assignment of such scores is based on the selection, comparability,and outcomes of the groups under investigation. A score of ≥ 6 indicated a highquality study.

    Statistical analysis

    The following formula was used for calculation of the prevalence rate of high SOX2 expression:(number of samples with high SOX2 expression/total number of samples)× 100; the standard error and 95%CIs were calculated as described previously[9]. The RevMan 5.3 software was used for statistical analysis (Review Manager, the Cochrane Collaboration, Oxford, United Kingdom). For dichotomous data (e.g., LNM, DM and clinicopathological data), odds ratios (ORs) and their respective 95%CIs were applied.Regarding prognostic markers (OS and DFS), HRs and their respective 95%CIs were integrated in the meta-analysis. Statistical heterogeneity was assessed using theI2statistical test, which was interpreted as a significant heterogeneity atI2> 50%. In such instance, a random effects model was applied. On the other hand, a fixed effects model was used when the heterogeneity was insignificant. Subgroup analyses were performed according to sample size, the type of primary cancer, and quality score.

    RESULTS

    Results of the search process

    Figure 1 shows the outcomes of the employed search process. The initial search yielded a total of 1120 records, from which 45 records were considered duplicates,while an additional 5 records were identified from the bibliographies of the resultant records. Therefore, 1080 records were screened for eligibility through their titles and abstracts. Subsequently, the full-text versions of 23 articles were examined for inclusion. Ultimately, 20 studies were included in the meta-analysis.

    Characteristics of the included studies

    Table 1 demonstrates the main characteristics of the included studies. A total of 2643 patients (60.88% males) were investigated for eight types of cancer, including cancers of the breast[10,11], cervix[12], colon[13], esophagus[14-16], head and neck[17-23], liver[24], lung[25],and stomach[26-29]. The sample sizes ranged between 20 and 307 patients. Excluding three studies in which the clinical stage was not reported[10,13,24], 1265 patients (54.98%)were at stage III or IV. Immunohistochemical staining was utilized in all studies to detect SOX2 expression. With respect to outcomes, only two studies did not report LNM[12,17], while DM was reported in 11 studies[12-14,17,19,20,22-24,26,27], OS in 11 studies[12,15-23,26], and DFS in 3 studies[17-19]. Two studies were performed in European countries[13,19], one in Africa[10], and the remaining studies in Asia. All of the included studies scored a NOS equal to or greater than 6, indicating the inclusion of highquality studies.

    Prevalence of high SOX2 expression and its relationship to the clinicopathological parameters

    The pooled prevalence of high SOX2 expression in different types of cancer was 46.22% (95%CI:39.07%-53.38%) with a significant heterogeneity among the included studies (I2= 94%). Subgroup analysis was performed to detect the sources of heterogeneity, yet it remained significant for most of the subgroups. As for the clinicopathological parameters, SOX2 expression was not significantly correlated to patient's age, sex and clinical stage as well as the size and differentiation of tumors(Table 2).

    Relationship between SOX2 expression and metastasis

    Although applying a random effects model yielded no remarkable association between high SOX2 expression and LNM (Figure 2A), the relationship was significant in the subgroup analyses for specific types of tumors, including cancers of the colon(OR = 4.15, 95%CI:1.43-12.09,P= 0.009), breast (OR = 2.78, 95%CI:1.50-5.50,P= 0.002,I2= 0%), and lung (OR = 1.74, 95%CI:1.02-2.89,P= 0.04) ( Table 3).

    Interestingly, SOX2 was highly expressed in distant metastatic tumors (OR = 1.79,95%CI:1.20-3.25,P< 0.008; Figure 2B) despite the existence of a significant heterogeneity between studies (I2= 57%). Such relationship was also consistent for hepatic (OR = 4.80, 95%CI:1.56-14.76,P= 0.006), colon (OR = 3.04, 95%CI:1.15-8.04,P= 0.03), and head and neck tumors (OR = 2.46, 95%CI:1.63-3.72,P< 0.001) ( Table 3).

    Relationship between SOX2 expression and patient prognosis

    As compared to low SOX2 expression, high SOX2 expression was significantly associated with shorter OS and the studies showed no heterogeneity (HR = 1.65,95%CI:1.34-2.04,P< 0.001,I2= 44%; Figure 3A). Similarly, the included studies showed a significantly shorter DFS when SOX2 was highly expressed without heterogeneity (HR = 1.54, 95%CI:1.14-2.08,P= 0.005,I2= 15%; Figure 3B).

    DISCUSSION

    Cancer biology involves a number of hallmarks that enable cellular division and spread, including continued proliferative signaling, initiation and maintenance of metastasis, and evasion of cell death[30]. SOX2 has exhibited various roles in these hallmarksviapromoting cellular proliferation through the induction of cyclin D3 transcription and enabling S-phase entry[31]as well as evading apoptotic signals by precludingORAI1expression and subsequently reducing store-operated Ca2+entry[32].The present meta-analysis showed that SOX2 contributed to the development of a metastatic phenotype to distant organs and its high expression was associated with shorter OS and DFS in patients with cancer.

    Figure 1 Flow diagram showing the search process used in the present study.

    SOX2 is one of the embryonic cell fate determinants which have been linked to increasing tumor aggressiveness, metastasis, and poor prognosis. In addition to SOX2,these factors, namely the Yamanaka factors[3], includeOct4,Klf4, andMyc, among others. SOX2 determines distinct cell fate decisions during embryonic developmentviaantagonization of CDX2, NKX2-1, MITF, and other tissue-specific factors[33]. In cancer, evidence from experimental studies has revealed different mechanisms of SOX2-mediated metastasis. Girouardet al[34]showed that the transduction of G361 cells, which normally express low SOX2 levels, to enhance SOX2 overexpression led to a 3.8-fold increase in invasiveness (P= 0.0004) and, on the other hand, SOX2 knockdown in melanoma cells resulted in a significant reduction of invasiveness and diminished matrix metalloproteinase (MMP)-3 expression by 87.8%. Furthermore,invasion and migration of cancer cells in colorectal cancer (CRC), malignant glioma,and laryngeal squamous cell carcinoma were attributed to MMP-2-mediated effects and this was associated with SOX2 overexpression[35-37]. Therefore, in the current study, it was not surprising that SOX2 overexpression was associated with LNM and DM in colon cancer and DM in head and neck cancer. MMP-2 is a type of IV collagenase that has been implicated previously in carcinogenesis and metastasis[38]. In general, MMPs comprise a family of zinc-dependent endopeptidases that degrade extracellular matrix proteins and they are involved in metastasisviaseveral aspects,including tumor invasion, angiogenesis, and establishing metastatic foci[39].

    In hepatocellular carcinoma, SOX2 induced cell invasion and hence was associated with DM. SOX2 expression was low in non-carcinogenic liver cells, moderate in noninvasive cells, and highest in the invasive cells[24]. Such an effect is mediated by enhancing cancer stemness properties through activation of the epithelial-tomesenchymal transition (EMT) process, which is characterized by remarkable activation of distinct transcriptional factors, including Snail, Twist, and Slug. The SOX2-Slug axis has been consistently reported not only in hepatocellular carcinoma but also in esophageal squamous cell carcinoma and muscle-invasive bladder cancer[24,40,41]. SOX2-mediated Slug expression was suppressed by inhibition of STAT3/HIF-1α signaling using siRNA, indicating a role of such pathway in the coexpression of SOX2 and Slug[40]. Nonetheless, the exact regulatory mechanisms between EMT and SOX2 and other stemness-related transcriptional factors,considering their contribution to cancer metastasis, have yet to be clearly revealed.Through its common activating effect on EMT, SOX2 exerts its metastatic potential in CRCviaa different mechanism. Activation of the WNT pathway, which is thought tobe critical for CRC tumorigenesis, was demonstrated in CRC and cisplatin-resistant lung adenocarcinoma cells[35,42].

    Table 1 Characteristics of the included studies

    In contrast to our results, in ovarian cancer cells, SOX2 overexpression increased phosphorylation of Src and FAK proteins[43], both of which are well-established as prometastatic proteins through their abilities to mediate EMT[44]. Additionally, SOX2 functionality was linked to the Hedgehog signaling pathway in controlling different hallmarks of prostate cancer, such as reduction of apoptotic death, increasing cellular proliferation, and augmenting the metastatic ability[45]. This was also confirmed by the effects of SOX2 silencing, where it lowered the migration capabilities of different prostate cancer cell lines by 11%-31%[45]. Similarly,SOX2gene knockout or silencing led to loss of tumorigenic properties and reduced cellular proliferation in lung cancer[46], glioblastoma[47], and pancreatic cancer[31]. Paradoxically, SOX2 overexpression was found in gastric cancer and could contribute to cellular invasion[48],while it was found to be significantly downregulated in the same type of cancer in other studies[28,49,50].

    In the present meta-analysis, SOX2 correlated with poor prognosis in different types of cancers. Other investigations have also indicated higher rates of recurrence and that its expression was associated with the parameters of worse outcome in primary cancers of the head and neck[51]. Furthermore, SOX2 was associated with advanced tumor stages in head and neck adenoid cystic carcinoma[52]. However, we failed to prove such a relationship, possibly because the included studies had to report at least one parameter of metastasis (LNM and/or DM) in addition to the prognostic data. Thus, several prognosis-relevant studies might have escaped inclusion.

    Table 2 Pooled effect of the relationship between SOX2 expression (high vs low) and the clinicopathological parameters of cancer patients in the included studies

    Given that SOX2 expression was detected not only in the nuclei of cancer cells but also in the their cytosols in hepatic cancer, pancreatic cancer and CRC[24,32,35], it is plausible that the intranuclear existence might explain its transcriptional role; yet, its functional role in the cytosol remains only fairly ununderstood. In light of the confirmed transcriptional roles, functional-depletion of SOX2,viaknockdown approaches using siRNA, is possible experimentally; although, its clinical application is challenging. Alternatively, researchers should strive to identify the possible regulatory mechanisms of SOX2 to tailor distinct targeted therapies accordingly.

    In conclusion, SOX2 has exhibited a significant metastatic potential in various types of cancer, including colorectal, head and neck, liver and breast. It can also be regarded as a poor prognostic indicator, and recurrence may be expected in patients with SOX2 overexpression. Different transcriptional regulation mechanisms of SOX2 are involved, yet promotion of the EMT was apparently of paramount importance.Implementing targeted therapies aimed to counteract high SOX2 expression might be beneficial to treat this deadly disease.

    Table 3 Subgroup analysis of the association between SOX2 expression (high vs low) and LMN and DM

    Figure 2 Forest plot of the association between SOX2 expression and lymph node metastasis and distant metastasis.

    Figure 3 Forest plot of the association between high SOX2 expression and lymph node metastasis and distant metastasis.

    ARTICLE HIGHLIGHTS

    Research background

    SOX2 is a significant regulator of pluripotent cellular transcription and it helps in the reprogramming of somatic cells to the pluripotent properties. The involvement of SOX2 in cancer biology has been recently demonstrated.

    Research motivation

    Metastasis comprises the most important aspect of cancer-related mortality. Linking SOX2 expression to metastasis and subsequently to patient's survival may open novel horizons for the implementation of future therapeutic strategies that target SOX2 biological pathways.

    Research objectives

    To investigate the association between SOX2 overexpression and the development of a metastatic phenotype as well as the survival patterns of patients with increased SOX2 expression.

    Research methods

    A meta-analysis was conducted, including studies that recruited patients with different types of cancer and reporting SOX2 expression as either “l(fā)ow” or “high”, and evaluating patient survival using the relevant analytical methods [overall survival (OS) and/or disease-free survival (DFS)].A comprehensive search of articles published between 2010 and 2018 was performed in distinct scientific databases.

    Research results

    A total of 20 studies involving 2643 patients (60.88% males) were included. SOX2 overexpression was significantly associated with distant metastasis (odds ratio = 1.79, 95%CI:1.20-3.25,P<0.008), while it was associated with lymph node metastasis only in subgroup analyses of cancers of the colon, breast, and lung. Both OS and DFS were shorter in patients expressing high SOX2,as compared to those with low SOX2 expression (hazard ratio = 1.65, 95%CI:1.34-2.04,P< 0.001 and hazard ratio = 1.54, 95%CI:1.14-2.08,P= 0.005, respectively).

    Research conclusions

    The present study adds a comprehensive insight into the significant role of SOX2 in distant metastasis of different types of cancers and its correlation to poor prognosis rather than the outcomes obtained by individual studies. In line with the increased research interest in SOX2, we showed that it can be used as a prognostic marker in cancer patients, while, on the other hand,new therapeutic strategies are urgently needed to target the biological pathways implicated in SOX2 overexpression for more effective cancer treatment.

    Research perspectives

    Targeting SOX2 expression in cancer regimens is warranted. Future research studies should focus on developing novel drugs as well as the identification of the cut-off values of poor prognosis.

    亚洲欧美中文字幕日韩二区| 欧美激情国产日韩精品一区| 人人妻人人澡人人爽人人夜夜 | 免费观看性生交大片5| 天天躁日日操中文字幕| 99热这里只有是精品在线观看| 中文字幕久久专区| 国产老妇女一区| 国产不卡一卡二| 免费大片18禁| 99九九线精品视频在线观看视频| 国产一区二区在线观看日韩| 一级黄片播放器| 午夜老司机福利剧场| 亚洲av免费高清在线观看| 三级毛片av免费| 欧美 日韩 精品 国产| 亚洲在线自拍视频| 久久久久国产网址| 深夜a级毛片| 舔av片在线| 国产麻豆成人av免费视频| 99久久人妻综合| 国内精品一区二区在线观看| 黄片无遮挡物在线观看| 麻豆国产97在线/欧美| 毛片女人毛片| 精品久久久久久久久久久久久| 伦理电影大哥的女人| av播播在线观看一区| a级毛片免费高清观看在线播放| 在现免费观看毛片| 国产精品麻豆人妻色哟哟久久 | 女人十人毛片免费观看3o分钟| 一级黄片播放器| 啦啦啦韩国在线观看视频| 亚洲国产高清在线一区二区三| 久久99热这里只有精品18| 国产免费视频播放在线视频 | 高清视频免费观看一区二区 | 国产v大片淫在线免费观看| 超碰97精品在线观看| 哪个播放器可以免费观看大片| 夜夜看夜夜爽夜夜摸| 人体艺术视频欧美日本| 国产黄色免费在线视频| 亚洲成人中文字幕在线播放| 精品久久久久久久久亚洲| 在线观看美女被高潮喷水网站| 国产乱来视频区| 午夜免费男女啪啪视频观看| 国产乱人视频| 夫妻午夜视频| 能在线免费观看的黄片| 可以在线观看毛片的网站| 边亲边吃奶的免费视频| 久久久国产一区二区| 五月天丁香电影| 青春草视频在线免费观看| 永久网站在线| 国产av不卡久久| 老司机影院成人| 联通29元200g的流量卡| 成人毛片60女人毛片免费| 亚洲熟妇中文字幕五十中出| 老司机影院成人| 啦啦啦韩国在线观看视频| 欧美精品一区二区大全| 亚洲av成人av| 亚洲国产色片| 成年女人在线观看亚洲视频 | 神马国产精品三级电影在线观看| 男女国产视频网站| 亚洲精品成人av观看孕妇| 天堂av国产一区二区熟女人妻| 中文天堂在线官网| 搡女人真爽免费视频火全软件| 亚洲国产精品专区欧美| 日韩成人伦理影院| 免费av不卡在线播放| 在线观看av片永久免费下载| 日韩中字成人| 男女边吃奶边做爰视频| 最后的刺客免费高清国语| 非洲黑人性xxxx精品又粗又长| 色尼玛亚洲综合影院| 国产伦理片在线播放av一区| 亚洲电影在线观看av| 亚洲欧美日韩无卡精品| 欧美精品国产亚洲| 亚洲aⅴ乱码一区二区在线播放| 最近的中文字幕免费完整| 又爽又黄a免费视频| 麻豆成人av视频| 1000部很黄的大片| 99久久精品热视频| 深爱激情五月婷婷| 日韩亚洲欧美综合| 蜜桃久久精品国产亚洲av| 日韩在线高清观看一区二区三区| 中文天堂在线官网| 一夜夜www| av在线观看视频网站免费| 菩萨蛮人人尽说江南好唐韦庄| 一级毛片电影观看| 亚洲精品国产av成人精品| 国产成人精品一,二区| 纵有疾风起免费观看全集完整版 | 国产精品国产三级国产专区5o| 国产午夜精品论理片| 美女主播在线视频| 国产亚洲一区二区精品| 久久精品国产亚洲av涩爱| 亚洲成人中文字幕在线播放| 日韩av在线大香蕉| 精品久久久久久久久久久久久| 永久网站在线| a级毛片免费高清观看在线播放| 天堂俺去俺来也www色官网 | 狂野欧美激情性xxxx在线观看| 男女视频在线观看网站免费| 丰满乱子伦码专区| 国产精品1区2区在线观看.| 纵有疾风起免费观看全集完整版 | 人妻系列 视频| 亚洲在久久综合| av国产免费在线观看| 午夜福利视频精品| 老女人水多毛片| 麻豆久久精品国产亚洲av| 亚洲精品国产成人久久av| 又爽又黄无遮挡网站| 女人久久www免费人成看片| 七月丁香在线播放| 国产精品久久久久久精品电影小说 | 在线观看一区二区三区| 一级毛片我不卡| 久久精品熟女亚洲av麻豆精品 | 好男人在线观看高清免费视频| 小蜜桃在线观看免费完整版高清| 日本色播在线视频| 97热精品久久久久久| 国产日韩欧美在线精品| 男女边摸边吃奶| 五月玫瑰六月丁香| 精品一区在线观看国产| 亚洲精品视频女| 亚洲av男天堂| 女人久久www免费人成看片| 亚洲欧美一区二区三区黑人 | 国产在视频线精品| 天堂av国产一区二区熟女人妻| 亚洲欧美日韩无卡精品| 国语对白做爰xxxⅹ性视频网站| 大又大粗又爽又黄少妇毛片口| 亚洲精品日韩在线中文字幕| 欧美性感艳星| 97热精品久久久久久| 黄片wwwwww| 国产一区二区在线观看日韩| 亚洲国产av新网站| 舔av片在线| 在线 av 中文字幕| 精品人妻一区二区三区麻豆| www.av在线官网国产| 国产精品福利在线免费观看| 丰满乱子伦码专区| 亚洲精品影视一区二区三区av| 少妇丰满av| 国产精品日韩av在线免费观看| 久久午夜福利片| 中文字幕亚洲精品专区| 一个人看视频在线观看www免费| 日本与韩国留学比较| 日韩强制内射视频| 最近2019中文字幕mv第一页| 精品国内亚洲2022精品成人| 亚洲国产高清在线一区二区三| 久久久久久伊人网av| 一个人观看的视频www高清免费观看| 干丝袜人妻中文字幕| 91狼人影院| 亚洲精品,欧美精品| 亚洲最大成人av| 狂野欧美白嫩少妇大欣赏| 秋霞伦理黄片| 亚洲欧美精品自产自拍| 日韩大片免费观看网站| 欧美xxxx黑人xx丫x性爽| 国产单亲对白刺激| 免费少妇av软件| 美女cb高潮喷水在线观看| 久热久热在线精品观看| 尾随美女入室| 2021天堂中文幕一二区在线观| 嫩草影院精品99| 三级毛片av免费| 国产精品人妻久久久久久| 亚洲成人精品中文字幕电影| 插阴视频在线观看视频| 亚洲精华国产精华液的使用体验| 菩萨蛮人人尽说江南好唐韦庄| 国产美女午夜福利| 久久久久久久久久久免费av| 久久久久久久午夜电影| 久久久久久久国产电影| 午夜福利网站1000一区二区三区| 欧美日韩视频高清一区二区三区二| 观看免费一级毛片| 黄片无遮挡物在线观看| 毛片女人毛片| 亚洲欧美日韩东京热| 亚洲精品色激情综合| 女人被狂操c到高潮| 插逼视频在线观看| 舔av片在线| 亚洲天堂国产精品一区在线| 人人妻人人澡欧美一区二区| 毛片女人毛片| 高清视频免费观看一区二区 | 日本三级黄在线观看| ponron亚洲| 国产高清有码在线观看视频| 大又大粗又爽又黄少妇毛片口| 日韩中字成人| 国产麻豆成人av免费视频| 国产精品一区二区在线观看99 | 国产日韩欧美在线精品| 美女主播在线视频| 久99久视频精品免费| 99久久九九国产精品国产免费| 日韩av免费高清视频| 晚上一个人看的免费电影| 一区二区三区高清视频在线| 18禁在线无遮挡免费观看视频| kizo精华| 国产 亚洲一区二区三区 | 精品人妻熟女av久视频| 女人久久www免费人成看片| 国产国拍精品亚洲av在线观看| 如何舔出高潮| 久久久亚洲精品成人影院| 校园人妻丝袜中文字幕| 非洲黑人性xxxx精品又粗又长| 亚洲国产精品成人综合色| 色视频www国产| 日韩成人伦理影院| 亚洲精品,欧美精品| 久久久国产一区二区| 男插女下体视频免费在线播放| 免费黄频网站在线观看国产| 国产一级毛片七仙女欲春2| 久久人人爽人人片av| 在线a可以看的网站| 亚洲最大成人av| av黄色大香蕉| 精品人妻视频免费看| 好男人在线观看高清免费视频| 国产成人精品福利久久| 欧美另类一区| 真实男女啪啪啪动态图| 免费观看a级毛片全部| 在线免费十八禁| 亚洲成色77777| 一级二级三级毛片免费看| 天堂影院成人在线观看| 欧美xxⅹ黑人| 国产精品三级大全| 精品人妻熟女av久视频| 看黄色毛片网站| 国产亚洲5aaaaa淫片| www.色视频.com| 亚洲av免费高清在线观看| 亚洲三级黄色毛片| 国产高潮美女av| 国产成人福利小说| 国产乱来视频区| 国产精品一区二区三区四区免费观看| 热99在线观看视频| 大香蕉97超碰在线| 日韩欧美一区视频在线观看 | 午夜免费激情av| av专区在线播放| 日本与韩国留学比较| 毛片一级片免费看久久久久| 日本三级黄在线观看| 国产精品一区二区性色av| 国产亚洲91精品色在线| 在线 av 中文字幕| 免费看不卡的av| 日韩中字成人| 亚洲高清免费不卡视频| 久久久久久久亚洲中文字幕| 国产精品久久久久久久电影| 一级a做视频免费观看| 99久国产av精品国产电影| 欧美另类一区| 免费黄色在线免费观看| 亚洲欧美日韩东京热| 亚洲怡红院男人天堂| 亚洲熟妇中文字幕五十中出| 97热精品久久久久久| 免费人成在线观看视频色| 亚洲av国产av综合av卡| 观看美女的网站| 中文字幕免费在线视频6| 最近中文字幕2019免费版| 国产av不卡久久| 欧美3d第一页| 精品国产一区二区三区久久久樱花 | 天天躁日日操中文字幕| 免费av观看视频| 777米奇影视久久| 中文字幕人妻熟人妻熟丝袜美| 精品久久久久久久久亚洲| a级毛色黄片| 男女啪啪激烈高潮av片| 久久久久网色| 免费观看av网站的网址| 在线观看免费高清a一片| 精品少妇黑人巨大在线播放| 国产高清国产精品国产三级 | 国产亚洲av片在线观看秒播厂 | 国产乱来视频区| ponron亚洲| 好男人在线观看高清免费视频| 九草在线视频观看| 亚州av有码| 人妻系列 视频| 日本-黄色视频高清免费观看| 最近中文字幕高清免费大全6| 午夜视频国产福利| 亚洲怡红院男人天堂| 精品人妻熟女av久视频| 久久精品国产亚洲av涩爱| av免费在线看不卡| 麻豆乱淫一区二区| 三级男女做爰猛烈吃奶摸视频| 久久久久久国产a免费观看| 亚洲不卡免费看| 国产午夜精品久久久久久一区二区三区| 亚洲最大成人手机在线| 99久久九九国产精品国产免费| 成人漫画全彩无遮挡| 欧美一级a爱片免费观看看| 日韩制服骚丝袜av| 免费看日本二区| 午夜日本视频在线| 亚洲精品日本国产第一区| 欧美最新免费一区二区三区| 亚洲精品久久午夜乱码| 免费人成在线观看视频色| 美女黄网站色视频| 蜜桃久久精品国产亚洲av| 亚洲欧美精品专区久久| 日韩 亚洲 欧美在线| 国产免费福利视频在线观看| 欧美日韩国产mv在线观看视频 | 国产91av在线免费观看| 日日啪夜夜撸| 亚洲四区av| av福利片在线观看| 欧美一区二区亚洲| 天堂网av新在线| 26uuu在线亚洲综合色| 少妇人妻精品综合一区二区| 免费无遮挡裸体视频| 亚洲自偷自拍三级| 成人鲁丝片一二三区免费| 精品国产一区二区三区久久久樱花 | 久久久久久久久久黄片| 国产单亲对白刺激| 久久99精品国语久久久| 午夜激情欧美在线| 国产爱豆传媒在线观看| 好男人在线观看高清免费视频| 欧美区成人在线视频| 欧美zozozo另类| 麻豆成人av视频| 亚洲精品国产成人久久av| 久久精品熟女亚洲av麻豆精品 | 午夜激情福利司机影院| 午夜福利高清视频| 男人爽女人下面视频在线观看| 夜夜看夜夜爽夜夜摸| 精品久久久精品久久久| 国产精品一区二区三区四区免费观看| 日本av手机在线免费观看| 在线播放无遮挡| 有码 亚洲区| 国产成人精品一,二区| 国内揄拍国产精品人妻在线| 久热久热在线精品观看| 91午夜精品亚洲一区二区三区| 午夜福利视频精品| 国产精品不卡视频一区二区| 欧美激情久久久久久爽电影| 国产成人freesex在线| 97超视频在线观看视频| 久久久久网色| 免费大片黄手机在线观看| 亚洲一级一片aⅴ在线观看| 国产精品国产三级国产专区5o| 中文字幕久久专区| 亚洲av成人精品一二三区| 成年免费大片在线观看| 欧美最新免费一区二区三区| 国产一区亚洲一区在线观看| 男人和女人高潮做爰伦理| 日韩电影二区| 三级国产精品欧美在线观看| 嫩草影院精品99| 国产久久久一区二区三区| 国产成人aa在线观看| 国产欧美日韩精品一区二区| 男女下面进入的视频免费午夜| videossex国产| 干丝袜人妻中文字幕| 三级男女做爰猛烈吃奶摸视频| 嫩草影院新地址| 国产精品人妻久久久久久| 精品久久久久久久久亚洲| 国产精品一区www在线观看| 成年版毛片免费区| 精品久久久久久久久亚洲| 国产精品国产三级国产专区5o| 日本黄大片高清| 最近中文字幕高清免费大全6| 亚洲三级黄色毛片| 亚洲怡红院男人天堂| 99热全是精品| 国产免费福利视频在线观看| 久久久精品94久久精品| 亚洲三级黄色毛片| 少妇丰满av| 乱系列少妇在线播放| 成人亚洲欧美一区二区av| 亚洲av电影在线观看一区二区三区 | 男女啪啪激烈高潮av片| 成人av在线播放网站| av天堂中文字幕网| 偷拍熟女少妇极品色| 亚洲国产日韩欧美精品在线观看| 麻豆国产97在线/欧美| 国产大屁股一区二区在线视频| 国产真实伦视频高清在线观看| 麻豆精品久久久久久蜜桃| 国产免费福利视频在线观看| 美女内射精品一级片tv| 成人亚洲精品一区在线观看 | 可以在线观看毛片的网站| 亚洲18禁久久av| 色尼玛亚洲综合影院| 日韩精品青青久久久久久| 久久精品夜色国产| 亚洲欧美一区二区三区黑人 | 亚洲精品日本国产第一区| 色网站视频免费| 久久韩国三级中文字幕| 麻豆成人av视频| 国产精品爽爽va在线观看网站| 日韩欧美一区视频在线观看 | 国产片特级美女逼逼视频| 欧美激情在线99| 亚洲国产日韩欧美精品在线观看| 91精品伊人久久大香线蕉| av.在线天堂| 久久精品夜色国产| 26uuu在线亚洲综合色| 国产色爽女视频免费观看| 久久精品综合一区二区三区| 久久精品国产亚洲av涩爱| 久久午夜福利片| 亚洲精品aⅴ在线观看| 建设人人有责人人尽责人人享有的 | 欧美成人午夜免费资源| 国产一区亚洲一区在线观看| 欧美日本视频| 男女视频在线观看网站免费| 永久免费av网站大全| 亚洲一区高清亚洲精品| 国产精品一及| kizo精华| 国产精品久久视频播放| 久久久亚洲精品成人影院| 久热久热在线精品观看| 国产欧美另类精品又又久久亚洲欧美| 国产亚洲精品av在线| 久久韩国三级中文字幕| 日韩欧美 国产精品| 亚洲精品中文字幕在线视频 | 夜夜看夜夜爽夜夜摸| 水蜜桃什么品种好| 看非洲黑人一级黄片| 久久久a久久爽久久v久久| 国产视频首页在线观看| 亚洲av二区三区四区| 国产片特级美女逼逼视频| 黄片无遮挡物在线观看| 国产大屁股一区二区在线视频| 一级毛片电影观看| 女人久久www免费人成看片| 亚洲精品日本国产第一区| 91aial.com中文字幕在线观看| 午夜久久久久精精品| 综合色av麻豆| 国产男女超爽视频在线观看| 日韩 亚洲 欧美在线| 26uuu在线亚洲综合色| 欧美97在线视频| 亚洲最大成人av| .国产精品久久| 最近2019中文字幕mv第一页| 精品国产三级普通话版| 秋霞伦理黄片| 一个人观看的视频www高清免费观看| 1000部很黄的大片| 国产精品蜜桃在线观看| 国产精品人妻久久久影院| 亚洲性久久影院| 一级毛片我不卡| 午夜福利在线在线| 天堂影院成人在线观看| 国产精品三级大全| 日韩在线高清观看一区二区三区| 超碰av人人做人人爽久久| 伦精品一区二区三区| 亚洲aⅴ乱码一区二区在线播放| 一个人看的www免费观看视频| 久久97久久精品| 伊人久久精品亚洲午夜| 淫秽高清视频在线观看| 国产亚洲精品av在线| 深爱激情五月婷婷| 伦精品一区二区三区| 国产黄片视频在线免费观看| 黄色一级大片看看| 少妇猛男粗大的猛烈进出视频 | 免费观看av网站的网址| 老司机影院成人| 22中文网久久字幕| 成人亚洲精品av一区二区| 国产黄a三级三级三级人| 国产精品一区二区三区四区免费观看| 人妻少妇偷人精品九色| 久久这里只有精品中国| 18+在线观看网站| 午夜福利在线观看吧| 亚洲精品乱码久久久久久按摩| 色尼玛亚洲综合影院| 国产高清国产精品国产三级 | 女人久久www免费人成看片| 久99久视频精品免费| 亚洲美女视频黄频| 免费看不卡的av| 午夜老司机福利剧场| 久久99蜜桃精品久久| 亚洲av成人精品一区久久| 久久99热这里只频精品6学生| 午夜福利网站1000一区二区三区| 精品久久久久久成人av| 综合色av麻豆| 你懂的网址亚洲精品在线观看| 超碰97精品在线观看| 亚洲熟妇中文字幕五十中出| 国产精品一区二区三区四区免费观看| 51国产日韩欧美| 精品少妇黑人巨大在线播放| 老司机影院成人| 男女下面进入的视频免费午夜| 国产在线男女| 亚洲va在线va天堂va国产| 亚洲乱码一区二区免费版| 在线观看人妻少妇| 久久99热这里只频精品6学生| 亚洲精品aⅴ在线观看| 免费黄网站久久成人精品| 国产亚洲最大av| 国产熟女欧美一区二区| 国产精品久久久久久久久免| 国产精品三级大全| 国产老妇女一区| 国产单亲对白刺激| 精品久久久久久久久av| 国产男女超爽视频在线观看| 成人鲁丝片一二三区免费| 国产国拍精品亚洲av在线观看| 国产白丝娇喘喷水9色精品| 久久久久性生活片| 五月玫瑰六月丁香| 免费无遮挡裸体视频| 人妻系列 视频| 国产欧美另类精品又又久久亚洲欧美| 免费大片黄手机在线观看| 最近的中文字幕免费完整| 色吧在线观看| 国产探花极品一区二区| 亚洲欧美一区二区三区国产| 免费电影在线观看免费观看| 麻豆成人av视频| 国产人妻一区二区三区在| 美女国产视频在线观看| 一个人看视频在线观看www免费| 亚洲成人久久爱视频| 日韩大片免费观看网站| 久久久久免费精品人妻一区二区| 国产精品熟女久久久久浪| 久久久久精品久久久久真实原创| 91精品一卡2卡3卡4卡| 亚洲四区av| 亚洲欧美成人综合另类久久久| 在线播放无遮挡| 男人爽女人下面视频在线观看| 精品一区二区免费观看| 不卡视频在线观看欧美|